Pharmacodynamics of Vancomycin and Other Antimicrobials in Patients with Staphylococcus aureus Lower Respiratory Tract Infections
Top Cited Papers
- 1 January 2004
- journal article
- clinical trial
- Published by Springer Science and Business Media LLC in Clinical Pharmacokinetics
- Vol. 43 (13), 925-942
- https://doi.org/10.2165/00003088-200443130-00005
Abstract
No abstract availableKeywords
This publication has 65 references indexed in Scilit:
- Linezolid versus Vancomycin for Methicillin‐ResistantStaphylococcus aureusInfectionsClinical Infectious Diseases, 2003
- Comparison of Mortality Associated with Methicillin‐Resistant and Methicillin‐SusceptibleStaphylococcus aureusBacteremia: A Meta‐analysisClinical Infectious Diseases, 2003
- Synercid plus vancomycin for the Treatment of Severe Methicillin-resistant Staphylococcus aureus and Coagulase-negative Staphylococci Infections: Evaluation of 5 CasesScandinavian Journal of Infectious Diseases, 2002
- Treatment of hospitalized patients with complicated Gram-positive skin and skin structure infections: two randomized, multicentre studies of quinupristin/dalfopristin versus cefazolin, oxacillin or vancomycinJournal of Antimicrobial Chemotherapy, 1999
- Staphylococcus aureuswith Reduced Susceptibility to Vancomycin Isolated from a Patient with Fatal BacteremiaEmerging Infectious Diseases, 1999
- The Importance of Pharmacokinetic/Pharmacodynamic Surrogate Markers to OutcomeClinical Pharmacokinetics, 1995
- The Influence of Serum Albumin and ??1-Acid Glycoprotein on Vancomycin Protein Binding in Patients with Burn InjuriesJournal of Burn Care & Rehabilitation, 1989
- Clinical Significance of Antibiotic Tissue PenetrationClinical Pharmacokinetics, 1989
- APACHE IICritical Care Medicine, 1985
- Prediction of Creatinine Clearance from Serum CreatinineNephron, 1976